Apparently new drugs are coming down the pike that give new hope to long term AIDS patients.
If you do a Google news search for “Merck, Pfizer” you will find that they are introducing an entirely new class of HIV drugs that the FDA has put on the fast track for approval as early as this summer.
We’re talking new generation drugs as well as next-generation versions of existing drugs that offer new options for patients who no longer respond to current drugs.
“The most desperately ill patients are getting a second chance,” said Dr. Jacob Lalezari, assistant professor at the University of California, San Francisco, and lead researcher in the study for Pfizer’s Maraviroc.
This is great news for all of us. Never give up hope.